Lofibra

Low vitamin B6 status can promote accumulation of homocysteine, a sulfur‑containing amino acid that can damage the endothelium, increase oxidative stress, and promote clot formation, all of which are relevant to cardiovascular disease and stroke. Large observational studies and cross‑sectional analyses have shown that people with lower plasma pyridoxal‑5‑phosphate (active B6) levels have higher rates of stroke and other vascular events, and in some cohorts low B6 was a stronger predictor of stroke or transient ischemic attack than homocysteine itself. The encouraging finding from meta‑analyses and clinical trials is that B‑vitamin combinations including B6 can lower homocysteine and modestly reduce the combined risk of stroke, myocardial infarction, and vascular death in high‑risk patients, suggesting that maintaining adequate B6 is one useful piece of broader cardiovascular prevention

In the brain, vitamin B6 (pyridoxine) is needed to produce neurotransmitters and to keep homocysteine in check, so low B6 status has been linked to both depressed mood and subtle cognitive problems such as slower processing and poorer attention in some adults. Observational work in older populations suggests that lower blood levels or intakes of B6 tend to track with worse performance on memory, executive‑function, and psychomotor‑speed tests, raising concern that marginal B6 status may contribute to age‑related cognitive decline. Clinically, when B6 deficiency coexists with depression, correcting it is viewed as one modifiable factor that may help support clearer thinking and better cognitive function alongside standard psychiatric and lifestyle treatments.

In the nervous system, vitamin B6 is essential for making the inhibitory neurotransmitter GABA, so significant deficiency can lower seizure threshold and lead to seizures or encephalopathy, particularly in infants but occasionally in adults. Classic pyridoxine‑dependent or B6‑responsive seizure syndromes in infants often present with refractory seizures that improve dramatically after B6 or pyridoxal‑5‑phosphate is given, highlighting how crucial this pathway is for brain stability. Clinically, this means that in patients, especially infants, with otherwise unexplained or treatment‑resistant seizures or encephalopathy, assessing and correcting B6 status is a low‑risk, potentially lifesaving step that should be considered early.

In both children and adults, vitamin E deficiency can contribute to retinopathy and visual impairment because α‑tocopherol serves as a key fat‑soluble antioxidant that protects photoreceptor cells and retinal membranes from cumulative oxidative damage. Clinical reports describe patients with prolonged low vitamin E status developing pigmentary retinopathy, reduced visual acuity, and abnormal electroretinograms, sometimes alongside peripheral neuropathy, which can improve partially when deficiency is identified and corrected. These neurosensory changes appear more frequently in settings of fat malabsorption or genetic disorders affecting vitamin E transport, highlighting the importance of monitoring vitamin E status in at‑risk groups with otherwise unexplained visual decline.

Vitamin C deficiency weakens collagen in capillary and vascular walls, so severe scurvy can present with ocular hemorrhages in the conjunctiva and retina that threaten vision if not treated. Case reports and small series describe retinal hemorrhages, flame‑shaped hemorrhages, and even retrobulbar bleeding compressing the optic nerve, which can lead to optic neuropathy and visual loss in advanced cases. The encouraging point is that, when vitamin C deficiency is recognized early and promptly repleted, many ocular hemorrhages and visual symptoms can partially or fully resolve, making it critical to consider vitamin C status in patients with otherwise unexplained ocular bleeding and visual complaints.

When vitamin C runs low, its impact isn’t just skin‑deep, it can also affect the heart and lungs, sometimes contributing to shortness of breath, fatigue, and fluid retention. Severe vitamin C deficiency has been reported as a reversible cause of pulmonary hypertension and right‑sided heart failure, with pressures in the lung circulation and cardiac strain improving after vitamin C is replaced. Broader cardiovascular research also links low vitamin C with higher blood pressure and stiffer arteries, while short‑term supplementation in some hypertensive or diabetic patients has lowered systolic blood pressure and improved arterial stiffness, suggesting that adequate vitamin C helps support healthier vascular tone and cardiac workload.